We are live on
!
Find out more
MVP
Miller Value Partners Portfolio holdings
AUM
$423M
1-Year Est. Return
49.14%
This Fund
S&P 500
This Quarter
Est. Return
+3.29%
1 Year Est. Return
+49.14%
3 Year Est. Return
+132.73%
5 Year Est. Return
+100.12%
10 Year Est. Return
+859.21%
AUM
$2.61B
AUM Growth
+$114M
(+4.6%)
Cap. Flow
-$61.4M
Cap. Flow
% of AUM
-2.35%
Top 10 Holdings %
Top 10 Hldgs %
31.98%
Holding
122
New
14
Increased
52
Reduced
48
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$52.2M |
| 2 |
Precigen
PGEN
|
+$24.4M |
| 3 |
GameStop
GME
|
+$13.3M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$8.84M |
| 5 |
Cisco
CSCO
|
+$7.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
+$43.9M |
| 2 |
Ares Capital
ARCC
|
+$28M |
| 3 |
NRF
NorthStar Realty Finance Corp.
NRF
|
+$21M |
| 4 |
TDAY
USA Today Co
TDAY
|
+$10.5M |
| 5 |
American Airlines Group
AAL
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.78% |
| 2 | Consumer Discretionary | 20.68% |
| 3 | Technology | 13.34% |
| 4 | Industrials | 11.55% |
| 5 | Communication Services | 8.68% |
Similar funds
WPC
ACM
BA
WTFG
MWP
MAMA
MI
AFWM
Miller Value Partners's Q2 2014 Portfolio in Review
As of Q2 2014, Miller Value Partners held 122 positions worth $2.61B, up 4.6% from $2.49B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Miller Value Partners's Q2 2014 filing shows 14 new, 52 increased, 48 reduced and 8 closed positions. Its largest new stake was Gilead Sciences: 670,075 shares worth $55.6M. The largest sale was QUESTCOR PHARMA INC, an estimated $43.9M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Technology.
- Miller Value Partners's largest Q2 2014 buy was Gilead Sciences: 670,075 shares worth $55.6M.
- Miller Value Partners added most to Precigen in Q2 2014, an estimated $24.4M increase.
- Miller Value Partners's biggest Q2 2014 reduction was Ares Capital, cutting an estimated $28M.
- Miller Value Partners fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $43.9M.
- Miller Value Partners's ten largest holdings make up 32% of its $2.61B portfolio in Q2 2014.
- Miller Value Partners opened 14 new positions and closed 8 in Q2 2014.
- Miller Value Partners's portfolio value rose 4.6% quarter-over-quarter to $2.61B.
Based on Miller Value Partners's 13F filing for Q2 2014, filed 14 Aug 2014.